Virus-induced polyclonal T cell activation is followed by apoptosis: Partitioning of CD8(+) T cells based on alpha 4 integrin expression

被引:25
作者
Christensen, JP
Ropke, C
Thomsen, AR
机构
[1] UNIV COPENHAGEN, PANUM INST, INST MED MICROBIOL & IMMUNOL, DK-2200 COPENHAGEN N, DENMARK
[2] UNIV COPENHAGEN, PANUM INST, INST MED ANAT, DK-2200 COPENHAGEN N, DENMARK
关键词
apoptosis; lymphocytic choriomeningitis virus; T cell activation;
D O I
10.1093/intimm/8.5.707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic infection with lymphocytic choriomeningitis virus (LCMV) is accompanied by marked splenomegaly, primarily reflecting the accumulation of CD8(+) T cells with an activated phenotype (e.g. VLA-4(hi)). Analysis of DNA content using 7-aminoactinomycin-D revealed that as many as 30% of CD8(+) T cells are cycling around day 6 post-infection and that virtually all cycling cells express a high level of VLA-4. In accord with the relatively stable CD4(+) cell number, only few cycling CD4(+) cells were observed, Following virus control, splenic lymphocyte numbers decreased gradually and during this period many apoptotic cells were detected in the white pulp using terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Flow cytometric analysis of DNA content revealed a high frequency of cells with subnormal levels of DNA in the CD8(+)VLA-4(hi) subset, whereas the frequency was low for other lymphocyte subsets studied (CD4(+), CD8(+)VLA-4(lo) and a cells), In addition, numbers of CD8(+)VLA-4(hi) cells constitute similar to 30% of splenocytes at the peak of the response and undergo preferential decrease during normalization of splenocyte numbers, Together these findings indicate that LCMV-induced activation of T cells is followed by apoptosis of many of the activated cells, Those CD8(+)VLA-4(hi) cells which do persist in LCMV immune mice are more sensitive to treatment with the cell-cycle-specific drug hydroxyurea than are phenotypically naive T cells, Our results therefore indicate that LCMV infection induces polyclonal activation of CD8(+) cells which is followed by apoptosis of most of the triggered cells while a smaller subset persists as a primed population which include cycling cells.
引用
收藏
页码:707 / 715
页数:9
相关论文
共 37 条
  • [1] VIRUS-LYMPHOCYTE INTERACTION - T-CELLS OF THE HELPER SUBSET ARE INFECTED WITH LYMPHOCYTIC CHORIOMENINGITIS VIRUS DURING PERSISTENT INFECTION INVIVO
    AHMED, R
    KING, CC
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (05) : 1571 - 1576
  • [2] THE SIGNIFICANCE OF LOW BCL-2 EXPRESSION BY CD45RO-T-CELLS IN NORMAL INDIVIDUALS AND PATIENTS WITH ACUTE VIRAL-INFECTIONS - THE ROLE OF APOPTOSIS IN T-CELL MEMORY
    AKBAR, AN
    BORTHWICK, N
    SALMON, M
    GOMBERT, W
    BOFILL, M
    SHAMSADEEN, N
    PILLING, D
    PETT, S
    GRUNDY, JE
    JANOSSY, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 427 - 438
  • [3] THE SPECIFIC RECOGNITION BY MACROPHAGES OF CD8(+),CD45RO(+) T-CELLS UNDERGOING APOPTOSIS - A MECHANISM FOR T-CELL CLEARANCE DURING RESOLUTION OF VIRAL-INFECTIONS
    AKBAR, AN
    SAVILL, J
    GOMBERT, W
    BOFILL, M
    BORTHWICK, NJ
    WHITELAW, F
    GRUNDY, J
    JANOSSY, G
    SALMON, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) : 1943 - 1947
  • [4] ANDERSSON EC, 1994, J IMMUNOL, V152, P1237
  • [5] LYMPHOCYTIC CHORIOMENINGITIS VIRUS-INFECTION IS ASSOCIATED WITH LONG-STANDING PERTURBATION OF LFA-1 EXPRESSION ON CD8(+) T-CELLS
    ANDERSSON, EC
    CHRISTENSEN, JP
    SCHEYNIUS, A
    MARKER, O
    THOMSEN, AR
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 42 (01) : 110 - 118
  • [6] IS T-CELL MEMORY MAINTAINED BY CROSS-REACTIVE STIMULATION
    BEVERLEY, PCL
    [J]. IMMUNOLOGY TODAY, 1990, 11 (06): : 203 - 205
  • [7] T-CELL MEMORY - NEW PERSPECTIVES
    BRADLEY, LM
    CROFT, M
    SWAIN, SL
    [J]. IMMUNOLOGY TODAY, 1993, 14 (05): : 197 - 199
  • [8] ACTIVATION OF CYTOKINE GENES IN T-CELLS DURING PRIMARY AND SECONDARY MURINE INFLUENZA PNEUMONIA
    CARDING, SR
    ALLAN, W
    MCMICKLE, A
    DOHERTY, PC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 475 - 482
  • [9] CHRISTENSEN JP, 1995, J IMMUNOL, V154, P5293
  • [10] DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123